Study of Influenza Virus Infection in Children Hospitalized in Spain in Two Consecutive Influenza Seasons
NCT04008823 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 907
Last updated 2019-07-05
Summary
This is an epidemiological, retrospective and observational study, by reviewing clinical histories, of children hospitalized for influenza virus infection, their comorbidities and the treatments that have been performed
Conditions
- Influenza Virus Infection
Interventions
- OTHER
-
Retrospective and observational epidemiological study, by review of clinical histories,
Retrospective and observational epidemiological study, by review of clinical histories,
Sponsors & Collaborators
-
Biogipuzkoa Health Research Institute
lead OTHER
Eligibility
- Sex
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-10-05
- Primary Completion
- 2017-11-02
- Completion
- 2017-12-13
Countries
- Spain
Study Locations
More Related Trials
-
Safety Study of CSL Limited's Influenza Virus Vaccine in the Paediatric Population Aged >= 6 Months to < 18 Years
NCT00825162 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A)
NCT00971321 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Children
NCT01198756 ·Status: COMPLETED ·Phase: PHASE3
-
Collaborative Efforts to Increase Flu Vaccination
NCT01403649 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months
NCT00311428 ·Status: COMPLETED ·Phase: PHASE4
-
Surveillance of Influenza Virus Shedding and Immunologic Response in Immunocompromised Children and Young Adults
NCT00998803 ·Status: COMPLETED
-
Safety and Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A)
NCT00964158 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345
NCT01702454 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
NCT00980005 ·Status: COMPLETED ·Phase: PHASE3
-
Influenza Vaccine in Children With Asthma
NCT04086628 ·Status: UNKNOWN
-
A Pilot Study of Influenza Viruses Isolated From Immunocompromised Children and Adolescents
NCT02352389 ·Status: COMPLETED
-
Prophylactic Efficacy of Relenza Against Influenza A and B
NCT01156701 ·Status: COMPLETED
-
A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in a Healthy Pediatric Population in the USA
NCT00958243 ·Status: COMPLETED ·Phase: PHASE2
-
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
NCT05832307 ·Status: RECRUITING ·Phase: NA
-
Characterization of Influenza-like Illness in Mexico
NCT01418287 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
NCT02212106 ·Status: COMPLETED ·Phase: PHASE4
-
Epidemiology and Clinical Presentation of H1N1 Infection in Children in Geneva
NCT01022931 ·Status: COMPLETED
-
Retrospective Observational Study on the Epidemiological Characteristics of Influenza Patients
NCT04110990 ·Status: UNKNOWN
-
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children
NCT00972517 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety, Tolerability & Immunogenicity of CSL Limited's Influenza Virus Vaccine In a Paediatric Population
NCT00700193 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical IGSP-CHOP Boston
NCT00428831 ·Status: COMPLETED
-
Trial to Evaluate the Safety and the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Healthy Children
NCT01096056 ·Status: COMPLETED ·Phase: PHASE1
-
Childhood Influenza Immunisation in General Practice Invitation Trial
NCT02921633 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity and Safety Study of GSK Biologicals' Influenza Vaccine When Administered in Children
NCT01196988 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Children
NCT00884182 ·Status: COMPLETED ·Phase: PHASE2